BridgeBio Pharma Inc (NASDAQ:BBIO)

49.36
Delayed Data
As of 4:05pm ET
 +0.91 / +1.88%
Today’s Change
36.20
Today|||52-Week Range
73.50
-30.59%
Year-to-Date
No recent news for BridgeBio Pharma Inc.

Today’s Trading

Previous close48.45
Today’s open48.25
Day’s range47.10 - 49.36
Volume18,323
Average volume (3 months)846,352
Market cap$7.6B
Data as of 4:05pm ET, 09/16/2021

Growth & Valuation

Earnings growth (last year)-53.38%
Earnings growth (this year)+6.11%
Earnings growth (next 5 years)-56.93%
Revenue growth (last year)-79.66%
P/E ratioNM
Price/Sales1,017.17
Price/Book106.99

Competitors

 Today’s
change
Today’s
% change
TEVATeva Pharmaceutical-0.05-0.56%
----
IMMBImmunotech Laborator...+0.00+400.00%
BGNEBeigene Ltd+10.45+2.79%
Data as of 5:43pm ET, 09/16/2021

Financials

Next reporting dateNovember 11, 2021
EPS forecast (this quarter)-$0.87
Annual revenue (last year)$8.2M
Annual profit (last year)-$448.7M
Net profit margin-5,439.74%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Palo Alto, California

Forecasts